Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent (ORIENT)
Multicenter, Randomized, Open Label, Parallel Group Study to Evaluate the Safety and Efficacy of Orsiro Hybrid Drug Eluting Stent
Sponsor: Chungbuk National University Hospital
Listed as NCT01826552, this PHASE4 trial focuses on Coronary Artery Disease and Coronary Heart Disease and remains completed. Sponsored by Chungbuk National University Hospital, it has been updated 6 times since 2013, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chungbuk National University Hospital
- Inha University Hospital
- Inje University
- Jeju National University Hospital
- Korea University
- Kyung Hee University Hospital at Gangdong
- SMG-SNU Boramae Medical Center
- Seoul National University Bundang Hospital
For direct contact, visit the study record on ClinicalTrials.gov .